Skip to Content

Clinical Trials Search Results

Showing 1-5 of 5

Sorted By:

  • GOG 0212

    A Randomized Phase III Trial of Maintenance Chemotherapy Comparing 12 Monthly Cycles of Single Agent Paclitaxel or CT 2103 (IND# 70177) Versus No Treatment Until Documented Relapse in Women With Advanced Ovarian, Primary Peritoneal, or Fallopian Tube Cancer who Achieve a Complete Clinical Response to Primary Platinum/Taxane Chemotherapy

  • GOG 0213

    A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel (Or Gemcitabine)Alone or in Combination with Bevacizumab (NSC #704865, IND #113912) followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer

  • GOG 0273

    Chemotherapy Toxicity in Elderly Women with Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

  • GOG-3001 Amgen 20101129/ENGOT –ov2/GOG-3001

    A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study of AMG 386 With Paclitaxel and Carboplatin as First-line Treatment of Subjects With FIGO Stage III-IV Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancers

  • GOG-3003

    A Randomized Phase II Study of VTX-2337 (IND #78,416) in combination with pegylated liposomal doxorubicin (PLD) vs. PLD alone in the treatment of recurrent or persistent epithelial ovarian, fallopian tube, or primary peritoneal cance

Showing trials 1-5 of 5

Also in this Section